{
    "id": 3798,
    "fullName": "TP53 R248L",
    "impact": "missense",
    "proteinEffect": "loss of function",
    "geneVariantDescriptions": [
        {
            "description": "TP53 R248L is a hotspot mutation that lies within the DNA-binding domain of the Tp53 protein (PMID: 22713868). R248L results in decreased Tp53 transactivation and repression, and resistance to apoptosis in cell culture (PMID: 8336941, PMID: 20570896, PMID: 18566217).",
            "references": [
                {
                    "id": 2227,
                    "pubMedId": 8336941,
                    "title": "Heterogeneity of transcriptional activity of mutant p53 proteins and p53 DNA target sequences.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/8336941"
                },
                {
                    "id": 2230,
                    "pubMedId": 20570896,
                    "title": "Dysregulation of p53/Sp1 control leads to DNA methyltransferase-1 overexpression in lung cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/20570896"
                },
                {
                    "id": 2397,
                    "pubMedId": 22713868,
                    "title": "Mutant p53: one name, many proteins.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/22713868"
                },
                {
                    "id": 2229,
                    "pubMedId": 18566217,
                    "title": "Potent synergy of dual antitumor peptides for growth suppression of human glioblastoma cell lines.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/18566217"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 7157,
        "geneSymbol": "TP53",
        "terms": [
            "TP53",
            "BCC7",
            "BMFS5",
            "LFS1",
            "P53",
            "TRP53"
        ]
    },
    "variant": "R248L",
    "createDate": "03/16/2015",
    "updateDate": "01/22/2016",
    "referenceTranscriptCoordinates": {
        "id": 95383,
        "transcript": "NM_000546",
        "gDna": "chr17:g.7674220C>A",
        "cDna": "c.743G>T",
        "protein": "p.R248L",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 10886,
            "approvalStatus": "Preclinical - Pdx",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, combination of Sprycel (dasatinib) and Demcizumab (OMP-21M18) treatment resulted in durable tumor inhibition in patient-derived animal models of lung adenocarcinoma harboring KRAS G12R and TP53 R248L (PMID: 26855149).",
            "molecularProfile": {
                "id": 27821,
                "profileName": "KRAS G12R TP53 R248L"
            },
            "therapy": {
                "id": 5671,
                "therapyName": "Dasatinib + Demcizumab",
                "synonyms": null
            },
            "indication": {
                "id": 3910,
                "name": "lung adenocarcinoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 8887,
                    "pubMedId": 26855149,
                    "title": "Combined inhibition of DDR1 and Notch signaling is a therapeutic strategy for KRAS-driven lung adenocarcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26855149"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 4336,
            "profileName": "TP53 R248L",
            "profileTreatmentApproaches": [
                {
                    "id": 3189,
                    "name": "p53 Activator",
                    "profileName": "TP53 R248L"
                },
                {
                    "id": 3190,
                    "name": "p53 Gene Therapy",
                    "profileName": "TP53 R248L"
                }
            ]
        },
        {
            "id": 27821,
            "profileName": "KRAS G12R TP53 R248L",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 95385,
            "transcript": "NM_001126114",
            "gDna": "chr17:g.7674220C>A",
            "cDna": "c.743G>T",
            "protein": "p.R248L",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 95383,
            "transcript": "NM_000546",
            "gDna": "chr17:g.7674220C>A",
            "cDna": "c.743G>T",
            "protein": "p.R248L",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 95382,
            "transcript": "NM_001126112",
            "gDna": "chr17:g.7674220C>A",
            "cDna": "c.743G>T",
            "protein": "p.R248L",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 95384,
            "transcript": "NM_001126113",
            "gDna": "chr17:g.7674220C>A",
            "cDna": "c.743G>T",
            "protein": "p.R248L",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}